Anti-D

DRUG3 trials

Sponsors

University of Aarhus, National Institute of Allergy and Infectious Diseases (NIAID), Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions

Dengue FeverHIV InfectionsHepatitis CIdiopathic Thrombocytopenic PurpuraThrombocytopenia

Phase 2

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

CompletedNCT00128882

University of AarhusIdiopathic Thrombocytopenic Purpura

Start: 2004-11-30End: 2008-12-31Updated: 2009-02-03

Phase 4

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

TerminatedNCT00239733

National Institute of Allergy and Infectious Diseases (NIAID)Hepatitis C, HIV Infections, Thrombocytopenia

Start: 2005-03-31End: 2010-02-28Updated: 2017-05-16

Unknown Phase

Role of Andi-d in Dengue Fever: a Pilot Study

CompletedNCT01443247

Post Graduate Institute of Medical Education and Research, ChandigarhDengue Fever

Start: 2010-09-30End: 2011-09-30Updated: 2011-09-29